Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Equity - Additional Information (Detail)

v2.4.1.9

Equity - Additional Information (Detail) (USD $)	1 Months Ended				12 Months Ended			0 Months Ended
Equity - Additional Information (Detail) (USD $)	Jul. 31, 2013	Apr. 30, 2013	Oct. 31, 2012	Sep. 30, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Nov. 06, 2014
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Public offering of Common Stock, shares						10,558,422
Proceeds from issuance of Common stock					$ 4,117,000	$ 92,399,000	$ 28,855,000
Common Stock Offering Price						70,000,000cndo_CommonStockOfferingPrice
Stock Issuance, Maximum Amount Of Proceeds Approved	200,000,000	45,000,000	30,000,000	75,000,000
Professional Fees					32,000us-gaap_ProfessionalFees
Share Price					$ 2.93us-gaap_SharePrice
After Amendment [Member] \| Preferred Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Capital Units, Authorized					15,000,000	15,000,000
Share Price					$ 0.001	$ 0.001
After Amendment [Member] \| Common Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Capital Units, Authorized					100,000,000	100,000,000
Share Price					$ 0.001	$ 0.001
Lindsay A. Rosenwald [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Proceeds from issuance of Common stock								$ 3,500,000
Share Price								$ 1.61

- Definition

Represents the offering price of common stock issued as of the balance sheet date.

+ References

No definition available.

+ Details

Name:	cndo_CommonStockOfferingPrice
Namespace Prefix:	cndo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents the amount of maximum proceeds approved and can be raised from issuance of stock as per shelf registration statement.

+ References

No definition available.

+ Details

Name:	cndo_StockIssuanceMaximumAmountOfProceedsApproved
Namespace Prefix:	cndo_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

It represents the stock issued during period shares issued for cash at market cost.

+ References

No definition available.

+ Details

Name:	cndo_StockIssuedDuringPeriodSharesIssuedForCashAtMarketCostShares
Namespace Prefix:	cndo_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of authorized capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.6-04.16(a))

-URI http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996

+ Details

Name:	us-gaap_CapitalUnitsAuthorized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.6-07.2(a),(b),(c),(d))

-URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 225

-Section 45

-Paragraph 3

-Subparagraph (k)

-URI http://asc.fasb.org/extlink&oid=6488370&loc=d3e13550-115849

+ Details

Name:	us-gaap_ProfessionalFees
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	cndo_AmendmentAxis=cndo_AfterAmendmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=cndo_LindsayARosenwaldMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: